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INTRODUCTION 
n 2010, the National Collegiate Athletic Association (NCAA) 
implemented a policy requiring all NCAA Division I athletes to be 
screened for the genetic condition sickle cell trait, an inherited 
condition that has been linked in athletes to exertional heat illness and 
exertional collapse, which are potentially fatal medical emergencies. 
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The screening policy was established as part of a legal settlement with 
the family of Dale Lloyd II, a nineteen-year-old football player at 
Rice University whose death after a football practice was attributed to 
sickle cell trait.1 Screening expanded to encompass Division II 
athletes in 2012, and will include all Division III athletes beginning in 
the 2014-15 academic year, placing it among the largest mandatory 
genetic screening programs in the United States.2 But the policy has 
spawned a heated debate, pitting the NCAA against professional and 
advocacy groups that criticize the sickle cell trait testing policy as 
illegitimate—due to the paucity of scientific evidence that such 
testing can save lives, or as unfair to players—due to the potential for 
the testing to result in racist consequences. 
A person is considered to have sickle cell trait if they have one 
copy of the mutated gene that codes for sickle hemoglobin; two 
copies of the mutated gene would indicate sickle cell disease, a life-
long, chronic medical condition. The condition of “carrier” or “trait” 
might not ever affect a person, besides the fact that that person could 
pass on the sickle cell gene to a child. An individual with sickle cell 
trait may, however, experience pain or life-threatening symptoms in 
certain unique situations such as skydiving, being at a high elevation, 
or participating in intense athletic exertion. Under current NCAA 
policy, a student-athlete must have a blood test to screen for the trait 
or provide results from a previous screening test before joining a 
team. Alternatively, the student-athlete may decline the test and sign a 
legal waiver, releasing the NCAA institution from liability in 
connection with the condition. 
At best, testing for sickle cell trait can inform student-athletes 
about potential health issues. This could potentially save lives,3 which 
is why Dale Lloyd’s family included it in their settlement.4 But there 
is no empirical evidence that such screening tests will be lifesaving. 
The leading group of physicians specializing in sickle cell trait, the 
American Society of Hematology, characterizes the testing as 
“medically and ethically inappropriate” and is firmly opposed to 
 
1 Beth A. Tarini et al., A Policy Impact Analysis of the Mandatory NCAA Sickle Cell 
Trait Screening Program, 47 HEALTH SERVS. RES. 446, 446–47 (2012). 
2 See Janis L. Abkowitz, President’s Column—Sickle Cell Trait and Sports: Is the 
NCAA a Hematologist?, AM. SOC’Y HEMATOLOGY (May 1, 2013), http://www 
.hematology.org/Publications/Hematologist/2013/10463.aspx. 
3 Tarini et al., supra note 1, at 446–61. 
4 Brett Zarda, Lawsuit Prompts NCAA to Screen Athletes for Sickle Cell, USA TODAY 
(July 2, 2010, 2:34 PM), http://usatoday30.usatoday.com/sports/college/2010-06-30-sickle 
-cell-ncaa-cover_N.htm. 
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sickle cell screening of college athletes.5 Its position is supported by 
five other organizations including the Sickle Cell Disease Association 
of America and the American Public Health Association.6 In addition, 
a federal-level committee advising the Secretary of Health and 
Human Services also opposes the testing policy.7 Yet neither the 
policy nor the controversy it has generated is widely known to 
student-athletes, their families, or their college communities. 
Instead, the screening requirement is one of “thousands of rules” in 
the four-hundred-page NCAA manual8: student-athletes are obliged to 
have the blood test for sickle cell—or to forego the possibility of legal 
action against the NCAA in the event of a medical catastrophe, just as 
they are prohibited from accepting remuneration connected to their 
status as athletes. Given the important debate surrounding genetic 
screening for sickle cell trait, the NCAA-mandated screening should 
not be buried in the mountain of rules; it should be on the table in 
discussions about the rights and status of student-athletes, and in 
debates over the fairness and legitimacy of NCAA policies. 
This Article takes as its starting point that a focused inquiry into 
the NCAA’s screening policy is necessary. We explore the moral 
obligations of those administering such testing to provide information 
about the meaning and results of the test, including its perceived 
benefits and potential risks. Such obligations are part of the long-
standing and well-described process of informed consent in medicine, 
and are fundamental to more recent discussions of shared decision 
making between doctors and patients. But it is not clear whether the 
obligations are upheld by the NCAA-mandated testing for sickle cell 
 
5 See ASH Policy Opposes Mandatory Sickle Cell Trait Screening for Athletic 
Participation, Recommends Universal Training Interventions & Additional Research, AM. 
SOC’Y HEMATOLOGY (Jan. 26, 2012), http://www.hematology.org/news/2012/7703.aspx; 
see also Abkowitz, supra note 2. 
6 Statement on Screening for Sickle Cell Trait and Athletic Participation, AM. SOC’Y 
HEMATOLOGY (Jan. 26, 2012), http://www.hematology.org/advocacy/policy-statements 
/7704.aspx. 
7 See Letter from R. Rodney Howell, Chairperson, The Sec’ys Advisory Comm. on 
Heritable Disorders in Newborns and Children, to The Honorable Kathleen Sebelius, 
Sec’y of Health and Human Servs. (June 14, 2010), available at http://www.hrsa.gov 
/advisorycommittees/mchbadvisory/heritabledisorders/recommendations/correspondence 
/sicklecell061410.pdf. 
8 Marc Edelman, The Future of Amateurism After Antitrust Scrutiny: Why a Win for the 
Plaintiffs in the NCAA Student-Athlete Name & Likeness Licensing Litigation Will Not 
Lead to the Demise of College Sports, 92 OR. L. REV. 1019, 1022, 1053–54 (2014); see 
NCAA, 2013–14 NCAA DIVISION I MANUAL §§ 13.11.2.1(g), 13.11.3.7.3, 13.11.3.8.1, 
13.11.3.9.1, 17.1.5.1 (2013). 
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trait as currently practiced. In addition, genetic testing is a special 
form of medical testing, with many arguing that those who conduct 
genetic testing are ethically required to provide genetic counseling.9 
Nevertheless, the NCAA has not made counseling obligatory. We 
focus on three aspects of the informed consent issue: (1) ensuring a 
process of informed consent or shared decision making and a process 
for genetic counseling, (2) preventing racist consequences of sickle 
cell screening, and (3) conducting research on the use of the sickle 
cell screening test to protect athletes. 
This Article will show that, as currently practiced, the NCAA 
sickle cell trait testing policy does not consistently inform student-
athletes about sickle cell trait or the health issues linked to it. Moving 
beyond arguments that the policy may be illegitimate and unfair, we 
will show that the policy as practiced places a substantial unmet 
burden on those involved with the testing who have the responsibility 
of informing and counseling student-athletes about the sickle cell 
screening test. More extensive training and education is needed for 
those working with student-athletes to carry out that responsibility, 
and student-athletes should have access to additional staff, including 
genetic counselors, to discuss the test. Open discussion should be 
offered to help student-athletes understand the genetic test, the 
possible implications of being a carrier for sickle cell trait, the reasons 
for the testing policy, the options to decline the test or have it done 
elsewhere, and the potential racist consequences that may be 
associated with this genetic test. This discussion would enable 
student-athletes to be active and fully-informed participants in the 
testing. 
I 
ENSURING THE PROCESS OF INFORMED CONSENT 
One of the most unsettling aspects of the NCAA policy on sickle 
cell trait screening involves the lack of direction to member 
institutions for ensuring informed consent. The fact that the testing is 
mandatory in some situations does not negate an ethical obligation to 
involve the student-athlete in the screening process. Genetic tests, in 
particular, have unique consequences not commonly encountered in 
 
9 Catherine Taylor et al., Sickle Cell Trait—Neglected Opportunities in the Era of 
Genomic Medicine, J. AM. MED. ASS’N (2014), available at https://jama.jamanetwork 
.com/article.aspx?articleid=1841474; Quality & Safety in Genetic Testing: An Emerging 
Concern, WORLD HEALTH ORG., http://who.int/genomics/policy/quality_safety/en/ (last 
visited Apr. 3, 2014); Abkowitz, supra note 2. 
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traditional medical care.10 Student-athletes, minimally, should be 
offered a discussion of alternatives to screening, potential 
consequences, and potential benefits in order to make an informed 
decision.11 In addition to the issues involved with genetic testing, the 
student-athlete has a distinctive relationship with the team physician. 
Physicians in other settings may involve genetic counselors to 
ensure patients are able to ask all questions about a genetic test. In 
addition, individuals who discover they have sickle cell trait may 
develop anxiety, and this can be alleviated through counseling and 
providing appropriate health related information.12 Yet, NCAA 
member institutions apparently do not offer genetic counseling, so 
special attention must be given to ensure that the student-athlete is 
comfortable asking questions and participating in decision making 
with the team physician, an individual who has a certain amount of 
control over the student-athlete’s opportunity to compete. All parties 
involved with the genetic testing of student-athletes should be made 
aware of the unique nature of these tests and the environment within 
which they are carried out so that they may ensure the student-athlete 
is able to participate in decision making with regards to his or her 
own care. 
A. A Process, Not a Form 
Decades ago, medicine followed an authoritarian model; informing 
was not emphasized13 and consent was conceived of as a signature on 
a piece of paper with very small print. Since then, the world of 
physicians and patients has undergone dramatic changes.14 The 
federal government has defined informed consent since 1993 as “a 
process, not just a form,” adding that “[i]nformation must be 
 
10 Dale Halsey Lea, Ethical Issues in Genetic Testing, 50 J MIDWIFERY WOMEN’S 
HEALTH 234 (2005); see Quality & Safety in Genetic Testing: An Emerging Concern, 
supra note 9; see also Abkowitz, supra note 2. 
11 See Neil A. Holtzman, Promoting Safe and Effective Genetic Tests in the United 
States: Work of the Task Force on Genetic Testing, 45 CLINICAL CHEMISTRY 732 (1999). 
12 Eila K. Watson et al., Psychological and Social Consequences of Community Carrier 
Screening Programme for Cystic Fibrosis, 340 LANCET 217 (1992). 
13 See JAY KATZ, THE SILENT WORLD OF DOCTOR AND PATIENT 142–47, 198–99 
(1984). 
14 See generally TOM L. BEAUCHAMP & JAMES F. CHILDRESS, PRINCIPLES OF 
BIOMEDICAL ETHICS 288–331 (6th ed. 2009); Yael Schenker & Alan Meisel, Informed 
Consent in Clinical Care: Practical Considerations in the Effort to Achieve Ethical Goals, 
305 AM. MED. ASS’N 1130 (2011). 
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presented to enable persons to voluntarily decide.”15 Today, without 
question, informed consent governs the practice of medicine. Under 
modern healthcare ethics, older notions of informed consent have 
evolved into a model of shared decision making: the doctor, a trusted 
expert with a duty to inform and act in ways that promote the 
patient’s best interests, engages the patient in a discussion such that 
doctor and patient come to a joint decision, “taking into account the 
best scientific evidence available, as well as the patient’s values and 
preferences.”16 The shared decision-making model and its requisite 
moral duties are firmly established; informing patients adequately and 
involving them in medical decisions is considered a standard for high-
quality medical care.17 The shared decision-making model also plays 
an important role in clinical controversies, where views of risks and 
benefits diverge so that it is not possible to arrive at a single 
interpretation of what is in a patient’s best interests.18 Further, shared 
decision making is key to the notion of patient-centered care, which is 
defined by the Institute of Medicine as “care that is respectful of and 
responsive to individual patient preferences, needs, and values.”19 
However, the history of medicine has not always focused on a 
patient-centered approach and, even today, resistance to ensuring 
informed consent remains. Though it is a legal requirement of 
medical care, 
Many physicians are skeptical about it or are even hostile to it. 
Some believe that it is impossible because patients can never 
understand medical situations as well as doctors. Other physicians 
regard informed consent as a meaningless legal ritual because they 
 
15 Office for Human Research Protections Tips on Informed Consent, U.S. DEP’T OF 
HEALTH & HUM. SERVS. (Mar. 16, 1993), http://www.hhs.gov/ohrp/policy/ictips.html. 
16 What is Shared Decision Making?, INFORMED MED. DECISIONS FOUND., http://www 
.informedmedicaldecisions.org/what-is-shared-decision-making/ (last visited Feb. 17, 
2014, 1:04 PM). 
17 Clarence H. Braddock III et al., Informed Decision Making in Outpatient Practice, 
282 J. AM. MED. ASS’N 2313 (1999); Cathy Charles et al., Decision-Making in the 
Physician-Patient Encounter: Revisiting the Shared Treatment Decision-Making Model, 
49 SOC. SCI. & MED. 651 (1999); Floyd J. Fowler Jr. et al., How Patient Centered Are 
Medical Decisions?: Results of a National Survey, 173 J. AM. MED. ASS’N INTERNAL 
MED. 1215 (2013). 
18 Martine C. de Vries, A Tango for Four: Deciding on Growth Hormone Therapy in 
Idiopathic Short Stature, 79 HORMONE RES. PEDIATRICS 2, 3 (2013) (citing Naomi T. 
Laventhal et al., Warning about Warnings: Weighing Risk and Benefit When Information 
is in a State of Flux, 79 HORMONE RES. PEDIATRICS (2013)). 
19 INSTITUTE OF MEDICINE, CROSSING THE QUALITY CHASM: A NEW HEALTH SYSTEM 
FOR THE 21ST CENTURY 3 (2001), available at http://www.iom.edu/Reports/2001 
/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx. 
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can almost always persuade patients to follow their 
recommendations.20 
And more than twenty years after the government’s 1993 statement 
on consent as “not just a form,”21 consent forms continue to be used 
in many settings—and continue to be criticized as failing to 
effectively inform patients.22 
Even where there is the intent to inform and provide opportunities 
for discussion, physicians and patients may not succeed in sharing 
decisions. Studies of actual interactions in healthcare show that 
frequently decisions are not fully informed or involve poor 
communication, incomplete discussion of the pros and cons of a given 
treatment choice, or a failure to attend to patient preferences.23 The 
federal Patient-Centered Outcomes Research Institute (PCORI), 
mandated to fund research that will provide the information needed 
for patients to reach “better and more personalized healthcare 
decisions,”24 has called for improving “the systems in which patients 
and clinicians make decisions” and removing “barriers to acting on 
the new information.”25 
Informing is also a legal issue; states have standards that doctors 
must meet when informing patients, and doctors can be found liable 
for failing to properly inform patients about tests, test results, and 
treatments.26 Canterbury v. Spence was the first decision to hold a 
physician liable for not adequately fulfilling the requirements of 
informed consent. More recent case law includes Truman v. Thomas 
 
20 BERNARD LO, RESOLVING ETHICAL DILEMMAS: A GUIDE FOR CLINICIANS 18 (4th 
ed. 2009). 
21 See Office for Human Research Protections Tips on Informed Consent, supra note 
15. 
22 See MARC A. RODWIN, CONFLICTS OF INTEREST AND THE FUTURE OF MEDICINE 
214–19 (2011). 
23 See Clarence H. Braddock III et al., Informed Decision Making in Outpatient 
Practice, 282 J. AM. MED. ASS’N 2313 (1999); Karen Sepucha & Albert G. Mulley Jr., A 
Perspective on the Patient’s Role in Treatment Decisions, 66 MED. CARE RES. REV. 54S, 
55S (2009). 
24 Joe Selby, Our Draft National Priorities and Research Agenda, PATIENT-CENTERED 
OUTCOMES RES. INST. (Jan. 23, 2012), http://www.pcori.org/blog/national-priorities-and   
-research-agenda/. 
25 Joe V. Selby et al., The Patient-Centered Outcomes Research Institute (PCORI) 
National Priorities for Research and Initial Research Agenda, 307 J. AM. MED. ASS’N 
1583, 1583 (2012). 
26 See Canterbury v. Spence, 464 F.2d 772, 786–88 (D.C. Cir. 1972). 
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and Pate v. Threlkel.27 These legal decisions uphold the basic tenet of 
informed consent that, “[e]very human being of adult years and sound 
mind has the right to determine what shall be done with his own 
body.”28 Typically, patients deserve to be told what a reasonable 
patient would expect to learn under the circumstances, the so-called 
“reasonable patient” standard, but this is a rapidly evolving area of 
law and one in which the standards of different states vary.29 
Within the shared decision-making model, genetic tests are 
accorded special status; the information required is categorized 
differently than other medical information because of the permanent 
nature of the findings, and as mentioned, informing about the tests 
may be done by genetic counselors in addition to, or in place of, 
physicians. According to the World Health Organization, “[t]he 
results of a genetic test can have a considerable impact on the life of a 
patient and his or her family; it is therefore essential that the quality 
of the test be assured, which includes the provision of non-directive 
counseling and other support services.”30 The President of the 
American Society of Hematology also acknowledged the role of 
genetic counselors: “[c]omprehensive and accurate counseling is 
especially important when screening for a genetic trait because having 
the trait is immutable.”31 
The legal situation surrounding genetic tests also has special 
features. Shannon Stevens gives the example of a 2001 case, EEOC v. 
Burlington Northern Santa Fe Railroad, where railroad employees 
claiming work-related injuries said they were required to submit 
blood samples but were not informed that the blood would be used for 
genetic testing.32 This situation led the EEOC to seek a preliminary 
injunction requiring the company to stop the testing.33 
 
27 Truman v. Thomas, 611 P.2d 902 (Cal. 1980); Pate v. Threlkel, 661 So.2d 278 (Fla. 
1995). 
28 Schloendorff v. Society of The New York Hospital, 211 N.Y. 125, 126 (1914). 
29 Krista J. Sterken & Michael B. Van Sicklen, Reshaping the Boundaries of Informed 
Consent in Wisconsin, 112 WISC. MED. J. (2013); see also Laurence B. McCullough & 
Frank A. Chervenak, Informed Consent, 34 CLINICS PERINATOLOGY 275 (2007). 
30 Quality & Safety in Genetic Testing An Emerging Concern, supra note 9. 
31 Abkowitz, supra note 2. 
32 Shannon K. Stevens, Baseball’s DNA Testing Policy Strikes Out: Genetic 
Discrimination in Major League Baseball, 41 SETON HALL L. REV. 813, 826 (2011). 
33 Id. 
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B. Applying Current Models of Informed Consent to the NCAA-
Mandated Sickle Cell Trait Test 
How do the models of shared decision making and patient-centered 
care apply to the screening test for sickle cell trait? Controversies 
over the effectiveness of screening tests are not limited to the test for 
sickle cell trait. For more than a decade, a debate has raged over the 
value of the prostate-specific antigen (PSA) test for prostate cancer: 
while it may detect an early form of cancer, the test may not prevent 
deaths and may cause harm by triggering unnecessary, potentially 
harmful, interventions.34 A doctor’s role is to inform a person 
considering a screening test about the reason the test is being 
considered, and discuss the varying opinions about the risks and 
benefits of the test. By this standard, anecdotal evidence from media 
reports and interviews of a convenience sample of student-athletes 
suggests that student-athletes in some programs are unacceptably 
uninformed about the screening test for sickle cell trait. 
To successfully promote informed consent regarding the sickle cell 
test, a team physician would discuss the nature of the test, information 
about sickle cell trait, the reason the test was mandated, and what 
effects a positive or negative result might have. Either the physician 
or a genetic counselor would be able to help the student-athlete 
understand how the results may affect current and future family 
members. For example, a student-athlete’s discovery that he or she 
carries sickle cell trait suggests that if the student-athlete’s partner 
carries it, their offspring are at risk for sickle cell disease. The 
positive test also can raise paternity issues; if neither the student-
athlete’s mother nor father carries the trait, then the student-athlete 
can deduce that they have at least one different parent. Paternity 
questions are a known risk of having this test, and the physician might 
want to mention this along with other potential risks and benefits, 
since paternity findings have implications for the student-athlete’s 
family.35 The test has further risks in the form of disclosure: as a 
 
34 See Michael Wilkes & Jerome Hoffman, PSA Tests Can Cause More Harm Than 
Good, S.F. CHRON. (Oct. 1, 2010), http://www.sfgate.com/opinion/openforum/article/PSA 
-tests-can-cause-more-harm-than-good-3172165.php; Michael Wilkes & Gavin Yamey, 
The PSA Storm: Questioning Cancer Screening Can Be a Risky Business in America, 324 
BRIT. MED. J. 431 (2002); H. Gilbert Welch & Peter C. Albertsen, Prostate Cancer 
Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 
1986–2005, 101 J. NAT’L CANCER INST. 1325 (2009). 
35 See Anneke Lucassen & Michael Parker, Revealing False Paternity: Some Ethical 
Considerations, 357 LANCET 1033 (2001); see also Lyn Turney, The Incidental Discovery 
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student who is also an athlete, one’s privacy may not be protected in 
the same way as a student who is a non-athlete, so a positive result 
could be publicly known. This can have far-reaching effects due to 
future risks of discrimination in employment and insurance.36 
But knowing that one has sickle cell trait could be beneficial in 
several ways. The most obvious benefit is that an affected and 
informed student-athlete could take precautions to prevent illness and 
death associated with exertional collapse. Another benefit is that 
student-athletes who have sickle cell trait will be aware of the risk 
that their children could have sickle cell disease before they begin 
planning to have families. This awareness is not standard,37 and it is a 
benefit others have wished for. In a study involving interviews with 
more than thirty parents of children with sickle cell disease, Patricia 
Kavanagh found the overwhelming majority did not learn they had 
sickle cell trait until they were pregnant or had a child with sickle cell 
disease.38 Further, all of the parents interviewed wished they had had 
this information before becoming pregnant, as it would have allowed 
them to be fully educated on their risks of having a child with sickle 
cell disease.39 
In addition to risks and benefits, the physician is able to discuss 
alternatives, such as providing previous test results, or agreeing to 
release the university and its employees from liability and playing a 
chosen sport without knowing if one is affected by sickle cell trait.40 
The possibility of waiving the test is essential to the notion of consent 
because a patient’s decision should not be manipulated or coerced.41 
However, in the view of one commentator, the option of a waiver 
suggests “that the NCAA has implemented this [testing] program 
 
of Nonpaternity Through Genetic Carrier Screening: An Exploration of Lay Attitudes, 15 
QUALITATIVE HEALTH RES. 620, 620–23 (2005). 
36 See Statement on Screening for Sickle Cell Trait and Athletic Participation, supra 
note 6; Rob Stein, Sickle Cell Testing of Athletes Stirs Discrimination Fears, WASH. POST 
(Sept. 20, 2010), http://www.washingtonpost.com/wp-dyn/content/article/2010/09/19/AR 
2010091904417.html. 
37 Taylor et al., supra note 9. 
38 E-mail from Patricia Kavanagh, Assistant Professor of Pediatrics, Bos. Univ. Sch. of 
Med. and Bos. Med. Cent., to Miriam Shuchman, Assoc. Professor of Psychiatry, Univ. of 
Toronto (Feb. 23, 2014) (on file with authors). 
39 Id. 
40 LO, supra note 20, at 20. 
41 JESSICA PIERCE & GEORGE RANDELS, CONTEMPORARY BIOETHICS: A READER 
WITH CASES 62–63 (2010). 
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simply to cover its ass.”42 And others have said much the same thing. 
Quick quotes the chief medical officer of the Sickle Cell Association 
of America, who described the testing policy as “screening for 
protection of the universities, not protection of the athlete.”43 
Some schools mandate that all student-athletes be screened; they 
do not present the waiver option as an alternative. Other schools, such 
as the University of California at San Diego (UCSD), strongly 
encourage student-athletes to be screened for sickle cell trait, rather 
than waive testing and release the institution from legal liability.44 At 
Virginia Tech, screening is encouraged, though student-athletes are 
responsible for the cost of the test.45 Quick reports that the NCAA has 
said schools should “promote testing as much as possible,” and 
should not encourage waivers, citing an NCAA “Question and 
Answer Document.”46 A team administrator at one school that does 
not present a waiver option told us this was justified because the 
school considers it essential to know a student-athlete’s sickle cell 
status. Yet, media reports suggest that other teams “collectively 
waive” the screening for all student-athletes, 47 perhaps to avoid the 
costs of the screening test. 
In these situations, a student-athlete is not free to make a decision 
to have or forgo screening. Even in those settings, though, if the test is 
offered, a physician is obligated to inform student-athletes about the 
test. An explicit acknowledgement of the test, and the reasons it is 
mandatory can contribute to the student-athlete’s knowledge of the 
 
42 Matt McCarthy, Did the NCAA Screw Up Another Player Health Decision?, 
REGRESSING (Dec. 5, 2013, 11:02 AM), http://regressing.deadspin.com/did-the-ncaa         
-screw-up-another-player-health-decision-1474781122. 
43 Heather R. Quick, Privacy for Safety: The NCAA Sickle Cell Trait Testing Policy and 
the Potential for Future Discrimination, 97 IOWA L. REV. 665, 669 n.20 (2012) (citing 
Michelle Brutlag Hosick, Protocol Decided for Sickle Cell Testing, NCAA.ORG (Apr. 13, 
2010), http://fs.ncaa.org/Docs/NCAANewsArchive/2010/d1/protocol_decided_for_sickle 
_cell_testing.html). 
44 See Student-Athlete Participation Information and Forums, UCSD (June 10, 2010), 
http://www.ucsdtritons.com/ViewArticle.dbml?ATCLID=204958637. 
45 See Sickle Cell Trait Testing, HOKIESPORTS.COM, http://www.hokiesports.com 
/sportsmed/policies/sickle-cell-trait-testing-policy.pdf (last visited Apr. 3, 2014). 
46 Quick, supra note 43, at 668 (citing NAT’L COLLEGIATE ATHLETIC ASS’N, 
QUESTION AND ANSWER DOCUMENT, NCAA DIVISION I PROPOSAL NO. 2009-75-B 2 
(June 2, 2010), available at http://www.gohofstra.com/fls/22200/pdf/SCTFAQs_SCI2.pdf 
?DB_OEM_ID=22200. 
47 Rose Eveleth, Exercising Caution: Intensive Athletic Activity Could Be Fatal to 
Those with Sickle-Cell Trait, SCI. AM. (Aug. 13, 2013), http://www.scientificamerican 
.com/article/athletic-activity-could-be-fatal-to-those-with-sickle-cell-trait/. 
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process and help him or her be a more involved and informed 
participant in the screening. In other words, the fact that the test is 
mandatory should not result in disregard for the notion of informed 
consent; student-athletes should be aware of the nature of the test and 
of the potential consequences of having sickle cell trait. 
A similar issue arises with respect to mandatory newborn screening 
in the United States: in some states, parents are not told that the 
screening is occurring, thus leaving them out of the decision-making 
process.48 This has been justified by a child welfare rationale: 
newborns are screened for inherited conditions such as 
phenylketonuria (PKU), requiring urgent, early treatment and 
therefore, public health officials have argued that the state may waive 
the parent’s usual right of informed consent to ensure appropriate 
treatment of affected newborns, under the state’s authority to promote 
child welfare.49 
However, Tarini and Goldenberg report that attitudes have changed 
recently regarding the need to inform parents, even though newborn 
screening is mandatory: 
Historically, the obstetrics community has resisted the responsibility 
to educate parents about newborn screening, contending that they 
are already tasked with discussing numerous prenatal tests with 
parents. This perspective seems to be changing, however; the 
American College of Obstetricians and Gynecologists recently 
recommended that prenatal providers give information about 
newborn screening to their patients through informational 
brochures, electronic sources, or discussion during prenatal visits.50 
In the case of a student-athlete, the NCAA does not claim that 
affiliate programs may test athletes for sickle cell trait without 
informing them, but NCAA literature does not specify the details of 
informed consent for the test, nor does it provide for genetic 
counseling about the meaning of the test, nor psychological support if 
the results of the test are positive. Educational information is provided 
to student-athletes and coaches regarding the physical implications 
 
48 See Ellen Wright Clayton, State Run Newborn Screening in the Genomic Era, or 
How to Avoid Drowning When Drinking from a Garden Hose, 38 J.L. MED. & ETHICS 
697, 697–99 (2010). 
49 THE PRESIDENT’S COUNCIL ON BIOETHICS, THE CHANGING MORAL FOCUS OF 
NEWBORN SCREENING: AN ETHICAL ANALYSIS 1–3, 75–76 (2008), available at 
https://bioethicsarchive.georgetown.edu/pcbe/reports/newborn_screening/introduction 
.html; Beth A. Tarini & Aaron J. Goldenberg, Ethical Issues With Newborn Screening in 
the Genomics Era, 13 ANN. REV. GENOMICS & HUM. GENETICS 381, 383–84 (2012). 
50 Tarini & Goldenberg, supra note 49, at 384–85 (citations omitted). 
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with respect to someone who carries the trait,51 but nowhere in the 
2013–14 NCAA Sports Medicine Handbook is any mention made of 
the special circumstances that genetic testing invokes, though much 
attention is given to the possible complications that might occur if a 
student-athlete has sickle cell trait.52 The moral duty to ensure 
student-athletes are fully informed and adequately counseled falls to 
physicians ordering or administering the test. In light of this, it is 
disturbing that student-athletes in some programs are screened for 
sickle cell trait without knowing it. The student-athletes deserve to 
have all of the information necessary to make an informed decision 
regarding whether to proceed with the genetic screening and this 
information should be provided even where the test is deemed 
mandatory. 
Scholars concerned about the NCAA requirement to screen 
student-athletes for sickle cell trait raised the issue of informed 
consent early on as one of several medical and ethical issues to be 
considered. In 2010, Bonham and colleagues asked the following 
questions: 
Will the NCAA assist student athletes and their parents in making 
informed decisions regarding testing and in understanding the 
implications of the test results? Will the first line test, hemoglobin 
solubility, be followed by a second test to eliminate false positives? 
What role will primary care providers play in screening and 
counseling? How will knowledge of their carrier status affect 
student athletes and their families? How will the athletic program 
and the institution protect the privacy of athletes who test positive? 
Surveillance and research aimed at understanding the program’s 
effects on universities, athletes, and families will need to be 
conducted if inadvertent harm is to be avoided.53 
Three years later, the president of the American Society of 
Hematology worried that the NCAA testing program would give 
student-athletes who test negative a false sense of security, leading 
them to ignore signs of health problems such as asthma, or the heart 
disorder known as long Q-T syndrome, both of which can also be a 
cause of athlete deaths.54 
 
51 Sickle Cell Trait: A Fact Sheet for Coaches, NCAA.ORG, http://www.ncaa.org/sites 
/default/files/NCAASickleCellTraitforCoaches.pdf (last visited Apr. 3, 2014). 
52 NCAA, 2013–2014 NCAA SPORTS MEDICINE HANDBOOK (2013), available at 
http://www.ncaapublications.com/productdownloads/MD13.pdf. 
53 Vence L. Bonham et al., Screening Student Athletes for Sickle Cell Trait—A Social 
and Clinical Experiment, 363 NEW ENG. J. MED. 997, 998 (2010). 
54 Abkowitz, supra note 2. 
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Informal conversations with a small number of student-athletes and 
anecdotal media reports indicate that the application of the sickle cell 
screening policy varies widely. Some schools provide excellent 
information, while others provide limited information, if any at all. 
The result is that some student-athletes are aware of the issue yet 
others are unaware of the sickle cell screening policy and even 
unaware that they have been screened for their carrier status. 
A few examples illustrate the large differences in how the policy is 
applied in practice. Media reports about Anya Covington, a three-time 
captain of the women’s basketball team at the University of 
Wisconsin, suggest that she and her coaches and trainers were well 
aware of her need as an individual with sickle cell trait to occasionally 
“pull herself out of a line drill in practice and take an extra water 
break now and then.”55 Covington told a reporter that her team trainer 
had helped her realize when she needed to sit out; her coach told the 
reporter, “[s]he’s going to go and go and go, so you have to manage 
her.”56 
Reports of Chris Carter’s basketball career at the Air Force 
Academy during 2011–12 suggest that Carter and his coaches were 
also well informed about his status as a sickle cell carrier.57 The Air 
Force Academy is in Colorado Springs, where altitude adds greater 
physical stress for athletes with sickle cell trait and places them at 
increased risk of dangers to their health.58 Carter and his coach may 
have been forced to grapple with his condition because he 
experienced an episode of dizziness early on that led to a few weeks 
off the court.59 Subsequently, Air Force staff monitored his workouts 
and in the fall of 2011 a team trainer told reporters, “[s]ickle cell trait 
is something that can be managed.”60 
A conversation with a rower at another university, by contrast, 
revealed she underwent the required physical exam and blood test at 
 
55 Dennis Punzel, UW Women’s Basketball: Sickle Cell Trait Hasn’t Kept Covington 
from Becoming Go-To Player for Badgers, MADISON.COM (Jan. 30, 2012), http://host 
.madison.com/sports/college/basketball/women/uw-women-s-basketball-sickle-cell-trait    
-hasn-t-kept/article_12874a9a-4af9-11e1-be75-001871e3ce6c.html. 
56 Id. 
57 See Frank Schwab, Carter Fights Through Sickle Cell Trait to Make Immediate 
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the start of her freshman year but did not know what the test was 
for.61 When she told her mother that there was a blood draw during 
the routine physical, her mother thought it was for a random drug test. 
The rower told us later that she did not feel comfortable asking 
questions about the nature of the blood test; she only learned what the 
test was accidentally when she took a class where it was discussed. 
Another conversation between one of the authors and two student-
athletes from a football team at one school showed a similar degree of 
misinformation. As part of a discussion of newborn genetic screening 
in a class the football players attended, information on the NCAA 
screening policy was given to the class. The student-athletes first said 
they had not been screened, but returned to class the following week 
saying that they found out they had been screened. When the student-
athletes brought up the class discussion at practice, a teammate told 
them the screening test had been part of their incoming physical. 
Anecdotes like these indicate that informed consent is not 
successfully attained with all athletes. 
Clearly, the practice of testing without explicitly informing 
student-athletes is outmoded. Recently, the Department of Health and 
Human Services (HHS) has ensured that patients in all fifty states can 
access the results of a blood test or other lab test without going 
through their doctor’s office.62 At the time of this HHS ruling, in 
2014, HHS Secretary Kathleen Sebelius said in a press release, 
“[i]nformation like lab results can empower patients to track their 
health progress, make decisions with their healthcare professionals, 
and adhere to important treatment plans.”63 Yet, student-athletes on 
some college campuses are commonly unaware that there is a lab 
result for them to check. 
These divergent practices on different campuses raise a critical 
issue for athletic programs and team physicians in light of the 
authority that programs wield over student-athletes. Institutional 
officials, such as coaches, control student-athletes’ playing time, 
eligibility for competition, and access to training resources, which are 
 
61 The authors have chosen to withhold the identity of the athletes in this section. 
Revealing any information regarding the schools they attended would compromise their 
anonymity. 
62 See HHS Strengthens Patients’ Right to Access Lab Test Reports, U.S. DEP’T 
HEALTH & HUM. SERVS. (Feb. 3, 2014), http://www.hhs.gov/news/press/2014pres/02 
/20140203a.html. 
63 Id. 
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among the most important aspects of the college sports experience. 
After devoting years of training to be selected for competition at this 
elite level, many student-athletes have finally reached the pinnacle of 
their aspirations and they want to compete. Any individual who 
controls their access to competition has power over the student-
athlete, and this unavoidable imbalance in power puts the student-
athlete in a unique and vulnerable situation. Quick describes the 
power differential this way: 
Student-athletes not only face the pressures of attempting to 
perform at a higher level of competition but also attempting to 
achieve a higher level of education. Also, student-athletes hope to 
create strong relationships with their coaches. In an attempt to 
create these relationships, student-athletes are more likely to follow 
the recommendations of these people without thinking of the 
consequences.64 
An awareness of the nature of these relationships is essential in 
ensuring informed consent about recommended medical tests and 
treatments. 
One might argue that a student-athlete might never be able to freely 
consent to a procedure due to the influences noted above. Some have 
raised this argument regarding a class-action lawsuit by football 
players against the National Football League (NFL) over the 
consequences of repeated head trauma.65 A major question in the 
litigation was whether the NFL failed to fully disclose information 
about the risks of the trauma, and in that context, one of the 
discussion points was “the imbalances of financial power between the 
NFL and most players.”66 However, others writing about sports 
medicine note that “all decisions are made within a context of some 
external influences.”67 In other words, while the context of the athlete 
may be different than that of a non-athlete, we are just trading some 
external influences for others—but this argument does not account for 
the vulnerable situation of student-athletes. 
In ensuring that athletes are fully informed, it may be valuable to 
consider the suggested protocols for screening for other genetic 
conditions. For example, counseling an individual undergoing a 
 
64 Quick, supra note 43, at 691 (citations omitted). 
65 Caleb Korngold et al., The National Football League and Chronic Traumatic 
Encephalopathy: Legal Implications, 41 J. AM. ACAD. PSYCHIATRY L. 430, 433 (2013). 
66 Id. 
67 Pam R. Sailors et al., Prescription for “Sports Medicine and Ethics,” 13 AM. J. 
BIOETHICS 22, 22 (2013). 
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genetic test for Huntington’s Disease, an inherited, fatal condition for 
which no treatment is available, may involve several meetings with a 
genetic counselor both before and after having the test.68 These 
discussions typically include at least one meeting after the test, where 
the counselor communicates the result of the test and educates the 
individual about it.69 Even for nonfatal conditions, discovering that 
one carries a genetic trait linked to certain health issues can cause 
anxiety and in many models of genetic testing, this is addressed via 
counseling and appropriate health education.70 Taylor et al. suggest 
that the appropriate route for counseling individuals about sickle cell 
trait is via primary care clinicians.71 As the anecdotal evidence 
suggests, at present no such process exists within the NCAA model 
and student-athletes in some programs are not informed of the results 
of their screening tests, foregoing any chance for counseling or 
greater education. 
There may be written or web-based materials that are intended to 
provide information. For example, at UCSD, student-athletes are 
provided with sickle cell fact sheets and instructed to watch an NCAA 
educational video.72 At one school, staff told us that a three-page 
handout is given to all student-athletes at an information session.  
Student-athletes are given the opportunity to ask questions and be 
involved in a discussion about sickle cell trait. The handout provides 
information about sickle cell trait: what it is, who may have it, how to 
get tested, information about training and competing, and the 
availability of options such as waiving the test. If the student-athlete 
voluntarily waives the testing, he or she is given another document 
that outlines the risks of waiving the test and his or her inability to 
pursue legal action against the NCAA or the institution if he or she 
has an injury because of sickle cell trait. Additionally, this waiver 
form requires the student-athlete to affirm that he or she has had time 
to ask any questions he or she may have. This appears to be an 
admirable model, especially considering the student-athletes are 
involved in face-to-face discussions about the information. Obtaining 
 
68 Guidelines for Genetic Testing for Huntington’s Disease, The Importance of a Team 
Approach, HEREDITY DISEASE FOUND. (Jan. 27, 2014, 1:05 PM), http://www.hd 
foundation.org/html/hdsatest.php. 
69 Id. 
70 Watson, supra note 12. 
71 Taylor et al., supra note 9. 
72 See DVD: The Student-Athlete with the Sickle Cell Trait (NCAA 2010), available at 
http://s3.amazonaws.com/ncaa/web_video/health _and_safety/sickle_cell/sickleCell.html. 
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a student-athlete’s signature on a form without discussing it does not 
constitute informed consent because there is no certainty that the 
student-athlete has been properly informed if a form is handed to him 
or her without discussion. 
C. Applying Current Models of Informed Consent to the Special Role 
of Team Physicians 
There is a pressing obligation to meet recognized standards set for 
informed consent for college athletes, but who bears the obligation? 
Team doctors are in a unique role in that they are interested in the 
health of the team as a whole as opposed to a personal physician 
concerned solely with the best interests of the patient. Much has been 
written about the potential for team physicians to face conflicts of 
interest and experience “divided loyalties” because they care for 
athletes but answer to the institution.73 The rules of informed consent 
still apply, but with caveats. 
An analogy might be made to physicians in the military or to 
company doctors, also known as industry employed physicians.74 The 
analogy to the military seems applicable to team doctors, because, as 
discussed earlier, coaches and trainers wield substantial authority over 
athletes. Annas writes of medical ethics in the military: 
There is no special medical ethics for active-duty military 
physicians any more than there is for Veterans Affairs physicians, 
National Guard physicians, public health physicians, prison 
physicians, or managed care physicians. The only question is 
whether there are “extreme contingencies” that justify physicians’ 
suspension of their medical–ethical obligations.75 
He also refers to the need for military doctors to treat only with the 
“voluntary and informed consent of the soldier-patient,” and quotes 
military authors as stating that physicians in the military are 
“[p]hysician first, [o]fficer second.”76 
 
73 See, e.g., Daniela Testoni et al., Sports Medicine and Ethics, 13 AM. J. BIOETHICS 4, 
4–6 (2013). 
74 B. Sonny Bal & Lawrence H. Brenner, Care of the Professional Athlete: What 
Standard of Care?, 471 CLINICAL ORTHOPAEDICS & RELATED RES. 2060, 2060–61 
(2013); Nancy M.P. King & Richard Robeson, Athletes Are Guinea Pigs, 13 AM. J. 
BIOETHICS 13 (2013); Charles Marsan, Professional Codes of Ethics as Leading 
Benchmarks, 13 AM. J. BIOETHICS 24 (2013). 
75 George J. Annas, Military Medical Ethics—Physician First, Last, Always, 359 NEW 
ENG. J. MED. 1087, 1087 (2008). 
76 Id. at 1088–89. 
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Industry employed physicians are described as having “ties to a 
third party” but with responsibilities “very similar to those of other 
physicians,” apart from the fact that they are not obliged to follow 
patients over time or provide continuity of care.77 Bal and Brenner 
view the obligations of the team doctor as an open question, asking 
what the norms are, “if there is a different standard of care for 
orthopaedic surgeons treating professional athletes.”78 They also 
wonder if such different norms, applied to an athlete suffering an in-
play injury, “include an abbreviated but meaningful process of 
informed consent.”79 Yet the notion of different norms seems 
inapplicable in the realm of college team doctors treating non-
professional, student-athletes. 
However, team doctors may view certain aspects of informed 
consent differently from a typical primary care physician. Typically, 
it is acceptable and appropriate for physicians to offer their opinions 
and recommendations regarding a diagnostic test or treatment, but this 
may be different in the case of team physicians acting on behalf of 
their teams and obliged to provide the test for sickle cell trait unless 
the athlete waives it. 
1. Preventing Racist Consequences 
Sickle cell trait, like sickle cell disease, disproportionately affects 
blacks with ancestry in certain parts of Africa and others with 
ancestry from Mediterranean or equatorial regions such as Greece or 
Central and South America.80 According to one estimate, perhaps 
four million people in the United States carry the trait, including eight 
percent of African Americans.81 A policy analysis concluded that if 
sickle cell trait screening of student-athletes were carried out 
effectively, 2147 athletes would be identified as carriers over a ten-
year period.82 Of these 2147 athletes, 1918 would be black, 25 would 
be Hispanic, and 204 would be of other races.83 To be clear, anyone 
of any race may carry the gene for sickle cell. However, in the United 
 
77 Marsan, supra note 74, at 25. 
78 Bal & Brenner, supra note 74, at 2062. 
79 Id. 
80 Sickle Cell Anemia, AM. SOC’Y HEMATOLOGY, http://www.hematology.org/Patients 
/Blood-Disorders/Anemia/5228.aspx (last visited Feb. 16, 2014). 
81 Abkowitz, supra note 2. 
82 Tarini et al., supra note 1, at 451–52. 
83 Id. 
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States, the majority of those who are carriers of the trait or are 
affected by the disease are African American. In light of this 
knowledge, it is important to understand the impact that race may 
have on informed consent, especially when it involves those with 
African American heritage. 
In a letter criticizing the NCAA testing requirement, the chair of a 
federal advisory committee expressed concern “because of the risk of 
stigmatization and discrimination against athletes with sickle cell trait 
and because the . . . request for screening does not provide . . . 
protection from the potential discriminatory use of such 
information.”84 The Sickle Cell Disease Association of America also 
believes the test carries a risk of stigmatization and discrimination,85 
and Quick describes how this might happen: a student-athlete could 
face discrimination by a potential employer “if the employer believes 
carrying the trait makes a candidate less qualified.”86 
These concerns are in line with current legal thinking: Stevens 
points out that in the context of employment, acquiring genetic 
information has led to concerns about discrimination because of 
“fears that an applicant’s genetic profile can be discriminatorily used 
to deny or terminate employment.”87 Quick describes current 
legislative efforts to protect employees against such discrimination, 
but concludes that the Genetic Information Nondiscrimination Act 
(GINA) does not fully cover the situation of student-athletes.88 
Discrimination is wrong for many reasons and it is also contrary to an 
NCAA core value of “fairness of opportunity to compete.”89 
Clearly the possibility of racist consequences is a risk that student-
athletes may be informed about, but there may be other, additional 
ways to consider the issue of race in informed consent. In the creation 
of laws regarding informed consent, there has been no consideration 
given to religious, ethnic, or racial perspectives.90 However, there is a 
documented trend of mistrust in the medical establishment by the 
 
84 Howell, supra note 7. 
85 Sickle Cell Trait and Athletics, SICKLE CELL DISEASE ASS’N AM., http://www.sickle 
celldisease.org/index.cfm?page=sickle-cell-trait-athletics (last visited Feb. 17, 2014). 
86 Quick, supra note 43, at 683. 
87 Stevens, supra note 32, at 836. 
88 Quick, supra note 43, at 670. 
89 Timothy Davis & Christopher T. Hairston, Majoring in Infractions: The Evolution of 
the National Collegiate Athletic Association’s Enforcement Structure, 92 OR. L. REV. 979, 
980 (2014). 
90 See Dayna Bowen Matthew, Race, Religion, and Informed Consent—Lessons from 
Social Science, 36 J.L. MED. & ETHICS 150 (2008). 
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African American community.91 This distrust has translated into 
lower participation rates in research by African Americans, and has 
also carried over into alarming differential trends in healthcare for 
African Americans. For example, African Americans “generally 
receive less health care than whites, and often it is received later in an 
illness, when it is not as likely to be effective.”92 Racial differences 
permeate our healthcare system, and whatever the reason, we would 
be naïve if we assumed they did not also affect the process of 
informed consent for a genetic condition that occurs 
disproportionately in African Americans. 
Sickle cell trait is also a test with a troubled racial history in the 
United States.93 Knowledge of this complicated past involving race 
and medicine can help to better inform patients. It may result in an 
extended amount of time dedicated to asking and answering 
questions, or an effort to introduce the subject of race and sickle cell 
testing as a means of taking cultural and racial differences into 
account when informing student-athletes about sickle cell trait 
screening. 
2. Conducting Research on the Screening Test 
In 2014, it is inappropriate to embark on a major medical initiative 
without evidence to justify it. More recently, some have advocated for 
an evidence-based approach to healthcare policy decisions.94 In 
addition, informed consent and shared decision making requires 
sharing evidence with patients. But there is limited evidence 
regarding the NCAA screening policy and gathering such evidence 
requires an active research program. Others have called on the 
National Institutes of Health and the Centers for Disease Control to 
study the issue of whether student-athletes with sickle cell trait are at 
increased risk of exercise-related sudden death,95 and further research 
 
91 See GREGORY E. PENCE, CLASSIC CASES IN MEDICAL ETHICS 241–50 (2nd ed. 1995) 
(discussing the Tuskegee study of syphilis and the use of deception on the African 
American subjects). 
92 RONALD MUNSON, INTERVENTION AND REFLECTION: BASIC ISSUES IN BIOETHICS 
788 (9th ed. 2nd prtg. 2011).  
93 See KEITH WAILOO & STEPHEN PEMBERTON, THE TROUBLED DREAM OF GENETIC 
MEDICINE: ETHNICITY AND INNOVATION IN TAY-SACHS, CYSTIC FIBROSIS, AND SICKLE 
CELL DISEASE 116–22 (2006). 
94 See, e.g., David Atkins et al., Making Policy When the Evidence is in Dispute, 24 
HEALTH AFF. 102 (2005). 
95 Howell, supra note 7. 
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is also required on the real-world use of the screening test, including 
studies of health outcomes, evaluations of other methods for 
preventing deaths related to sickle cell trait, and studies of whether 
the screening can be practiced in a fair and nondiscriminatory way.96 
The need for empirical research on sickle cell trait and the NCAA 
policy is underscored when one considers the intense debate over 
whether the screening is necessary or valuable. Several groups have 
called for the policy of mandatory screening for sickle cell trait to be 
reversed.97 Other experts have suggested the policy be viewed as 
experimental until there is data to show that it is effective.98 
To take just one example of the need for research, there is limited 
evidence that a student-athlete who knows he or she has sickle cell 
trait could be protected by that knowledge. The policy analysis 
referenced earlier concludes that under the NCAA screening policy, 
screening could prevent the deaths of seven student-athletes over the 
course of a decade, but only if one assumes that every athletic 
program involved is using a “100 percent effective intervention” for 
students found to be carriers of sickle cell trait.99 Informal reports 
suggest that the current levels of intervention by a student’s coach, 
trainers, or fellow athletes are less than one hundred percent effective, 
so the hoped-for goal of saving lives by preventing athletes from 
experiencing physical crises that could be secondary to sickle cell trait 
rests on assumptions that may not be met at many college athletic 
programs. 
Other areas where research is needed become apparent from 
reviewing the NCAA handbook. After a positive result is recorded on 
a sickle cell solubility test, the result should then be confirmed with a 
second test due to the inadequacies of the solubility test. The NCAA 
handbook states, “screening positives must be confirmed with 
additional diagnostic testing such as hemoglobin electrophoresis or 
high performance liquid chromatography (HPLC).”100 Yet in one 
published report on athletes with sickle cell trait who had died 
 
96 See Bonham et al., supra note 53; see also Abkowitz, supra note 2; Jonathan C. 
Goldsmith et al., Framing the Research Agenda for Sickle Cell Trait: Building on the 
Current Understanding of Clinical Events and Their Potential Implications, 87 AM. J. 
HEMATOLOGY 340 (2012). 
97 See, e.g., Howell, supra note 7; see also Abkowitz, supra note 2. 
98 Bonham et al., supra note 53, at 999; Statement on Screening for Sickle Cell Trait 
and Athletic Participation, supra note 6. 
99 Tarini et al., supra note 1, at 451. 
100 2013–2014 NCAA SPORTS MEDICINE HANDBOOK, supra note 52, at 94. 
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suddenly, several had no hemoglobin electrophoresis recorded.101 
Research on the process for requesting and checking the confirmatory 
test, and quality assessment or “implementation” research on the 
implementation of the screening test policy, could undergird the 
screening test policy with information about best practices. 
The NCAA handbook also notes that if the confirmatory test is 
positive, athletes “should be offered counseling on the implications of 
sickle cell trait, including health, athletics and family planning,”102 
but it is not known if any of the NCAA member schools provide such 
counseling, and it is not clear if student-athletes would be receptive to 
it. Given the importance of genetic counseling for such testing, and 
the potential for athletes who test positive for sickle cell trait to 
experience anxiety over the result, the actual availability of 
counseling and the attention to the mental health needs of those 
athletes who discover they are carrying sickle cell trait could be 
additional foci of research. 
Perhaps the most significant research deficiency is the lack of 
evidence that the screening test could save lives.103 The NCAA 
handbook alerts athletes and programs to the intended use of the test 
results: “[s]creening can be used as a gateway to targeted precautions. 
Precautions can enable student-athletes with sickle cell trait to thrive 
in their sport.”104 The NCAA handbook also recommends several 
steps that athletes and programs should take in the instance of an 
athlete who is positive for sickle cell trait to prevent bad outcomes. 
For example, deaths related to sickle cell trait are linked to heat and 
the student-athlete’s hydration; they typically occur early in training, 
such as the first day or the first week; and they are associated with the 
sorts of high-effort drills known as “gassers,” or the intense station or 
“mat” drills used in football practices.105 The NCAA recommends 
that student-athletes with sickle cell trait take “precautions” such as 
setting their own pace and using adequate rest and recovery between 
repetitions, especially during “gassers” and “mat” drills.106 But there 
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is no data attesting to the feasibility and actual use of these 
recommended preventive steps. 
In an analysis of twenty-three athletes whose deaths were linked to 
sickle cell trait, none died suddenly; all experienced gradual 
deterioration over several minutes and, for all but one, that 
deterioration happened during a conditioning drill.107 The analysis 
concludes, “[u]nderstanding the risks, mechanisms, and event triggers 
of [sickle cell trait] may allow lifesaving alterations in training 
methods to be implemented,”108 and in a subsequent publication, the 
same authors describe deaths linked to sickle cell trait as “potentially 
preventable with vigilance, a high index of suspicion, and effective 
treatment strategies.”109 The authors of a 2010 case report on a 
nineteen-year-old college football player who died following a 
training run in Texas also conclude that following simple precautions 
for athletes who test positive for sickle cell trait may prevent such 
tragedies.110 But these opinions are not yet backed by evidence from 
scientific studies. 
The NCAA advises institutions to provide an environment in which 
the student-athlete can “activate” the recommended precautions,111 
and it endorses the list of ten preventive steps developed by the Inter-
Association Task Force for Preventing Sudden Death in Collegiate 
Conditioning Session, which includes as item three, “[d]o not use 
exercise and conditioning activities as punishment,” and as item four, 
“[e]nsure proper education, experience and credentialing of strength 
training and conditioning coaches.”112 However, it is not clear how 
student-athletes, trainers, coaches, or athletic directors learn to be 
vigilant about sickle cell trait and its effects on athletes, nor is there 
research assessing whether NCAA-recommended policies are feasible 
at athletic programs. Informal data and anecdotal media reports 
underscore the need for this sort of research by suggesting that the 
culture of a typical college athletic practice varies widely. 
At Oklahoma University, according to media reports, basketball 
player Danielle Robinson tested positive for sickle cell trait during the 
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athletic program’s “routine” blood work.113 Danielle is monitored 
during times of exertion and is monitored especially closely during 
preseason training.114 Her preseason training is gradual; she also sits 
out occasional sprints and avoids all-out exertion lasting longer than 
two to three minutes. At the University of Tulsa, a football player 
with sickle cell trait had what his family’s lawyer later referred to as 
“these sickle cell attacks” more than once and the Tulsa trainers knew 
how to treat it, according to the lawyer.115 Years later the former 
player died after a boxing match.116 
But at other schools, the athletic culture is not one in which trainers 
and student-athletes are accustomed to taking such steps as having 
students “set their own pace.” Moreover, there are suggestions that in 
college sports programs, physical suffering is expected as part of a 
difficult workout. A 2011 report in the Los Angeles Times described a 
series of incidents, including one at the University of Iowa, in which 
vigorous football training situations led to the condition known as 
rhabdomyolysis among multiple team members.117 A similar incident 
after an “immersion camp” for the McMinnville, Oregon, high school 
football team garnered national headlines in 2010, when about thirty 
players suffering from symptoms of rhabdomyolysis were referred to 
the hospital, with three requiring emergency surgery.118 
At Slippery Rock University, according to a lawsuit filed after the 
death of a twenty-one-year-old basketball player, the basketball team 
was asked to do a third practice one day that was described as an 
“insanity workout . . . intended to serve as punishment for the entire 
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team.”119 At the University of Central Florida, in 2008, a quarterback 
who transferred to a different school said that he and his teammates 
requested water from the athletic trainers “at your own risk” because 
the coach would swear if an athlete interrupted a workout.120 
A reporter with a Florida paper interviewed a number of players 
about the issue of overly strenuous off-season workouts. “Some 
blame a culture that pushes for toughness, one where players run for 
punishment and athletic trainers might be intimidated by millionaire 
head coaches who aren’t educated on the risks associated with sickle 
cell trait,” she wrote.121 Media reports also discuss the role of athletic 
trainers, who often have the responsibility of deciding whether to pull 
a player out of a drill session or a workout: “some veteran athletic 
trainers admitted it can be intimidating saying no to a coach who 
wants a player to finish a drill.”122 The National Strength and 
Conditioning Association and the National Athletic Trainers’ 
Association convened a task force in January 2012 that recommended 
enacting educational requirements and minimum standards to ensure 
that appropriately-trained coaches are hired,123 and an op-ed 
commenting on the task force notes that the absence of such standards 
“is thought to be a major contributor to the abusive behavior and 
inappropriate training programs resulting in unnecessary deaths.”124 
Researchers could study the culture of college athletic practices via 
qualitative methods or by testing experimental interventions, but as 
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yet, there is very little scientific data on the culture of practice and 
therefore the evidence of a problem is anecdotal. 
Balancing evidence, values, and resources “can seem particularly 
difficult when decision makers are asked to set policy concerning a 
clinical intervention where there is no consensus about the 
evidence.”125 But it is difficult, if not impossible, to achieve a 
consensus when the evidence is lacking. The dearth of evidence on 
exertional heat illness was underscored in 2008, when the American 
College of Sports Medicine convened a roundtable aimed at achieving 
consensus regarding “the best guidance to return athletes and soldiers 
to activity” following an episode of exertional heat illness.126 Due to 
the deficiencies in available evidence, evidence-based 
recommendations were not feasible.127 Though the United States 
Army later issued recommendations for soldiers who suffered 
exertional heat illness, a subsequent report on the Roundtable 
concluded: “[t]he currently available science cannot support a high-
level, evidence-based, consensus return-to-play document, and much 
work has yet to be accomplished. The panel strongly believes this 
document provides a strong foundation for future clinical and bench 
research in this vitally important area.”128 
In the case of the sickle cell test, the lack of evidence for its value 
in promoting athletes’ health and welfare has prompted calls to 
implement universal precautions instead of screening.129 Universal 
precautions refer to minimal conditions for all student-athletes that 
include reducing dehydration, monitoring for heat related illness, and 
monitoring for exercise-related illness130: ideally, such conditions 
could eliminate the need for knowledge of a student-athlete’s sickle 
cell status because no student-athlete would be put in a situation that 
would induce exercise-related collapse. The United States Army has 
instituted universal precautions to protect all soldiers from exposure 
to extreme training environments, and the Army’s heat illness 
 
125 Atkins et al., supra note 94, at 102. 
126 Francis G. O’Connor et al., American College of Sports Medicine Roundtable on 
Exertional Heat Stroke—Return to Duty/Return to Play: Conference Proceedings, 9 
CURRENT SPORTS MED. REP. 314, 319 (2010). 
127 Id. at 320. 
128 Id. 
129 See Sickle Cell Trait and Athletics, SICKLE CELL DISEASE ASS’N AM., 
http://www.sicklecelldisease.org/index.cfm?page=sickle-cell-trait-athletics (last visited 
Feb. 17, 2014). 
130 Id. 
SMITH (DO NOT DELETE) 6/12/2014  11:26 AM 
1154 OREGON LAW REVIEW [Vol. 92, 1127 
prevention programs are credited with leading to a marked drop in the 
rate of hospitalization for heat illness in soldiers.131 However, 
exertional heat illness remains a common cause of hospitalization 
during intensive military training132 and heat exposure still 
occasionally and tragically claims soldiers’ lives.133 Further research 
is required to discover the effects of military policies in this area. 
Research is also required on specific sports that place student-
athletes at greater risk. In an analysis of case reports, the American 
College of Sports Medicine found that exercise collapse associated 
with sickle cell trait in NCAA student-athletes occurred primarily in 
American football training.134 Further, the typical scenario for an 
exercise collapse event involved characteristics such as, “day 1 of 
conditioning, newly arrived at altitude, just returning from a vacation, 
or a sudden increase in the intensity of a conditioning drill.”135 
Experimental research could test the effect of eliminating the 
“gassers,” “insanity workouts,” and punishment drills mentioned 
previously from athletes’ training. 
There are signs that the NCAA is interested in encouraging 
research. In 2013, the organization appointed a chief medical officer 
for the first time;136 in 2014, they put out a call for research 
proposals;137 and at some point in the future, the NCAA’s Concussion 
Task Force will analyze data from leagues that restrict full-contact 
football practices to twice a week.138 To date, the NCAA’s medical 
focus seems to be restricted to the issue of concussions—a response 
to multiple pressures, including suggestions from elected officials that 
Congress needs to investigate the NCAA due to its failure to protect 
student-athletes from the short- and long-term effects of sustaining 
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multiple concussions.139 But practices surrounding the NCAA blood 
test program for sickle cell trait warrant similar scrutiny. No doubt, 
the NCAA intends to prevent athlete deaths, but making college 
athletics safer requires evidence to inform policy. 
CONCLUSION: NCAA OBLIGATIONS REGARDING THE TEST FOR 
SICKLE CELL TRAIT 
The NCAA policy of mandatory sickle cell trait testing, as 
currently written and practiced, is not achieving the NCAA’s 
objectives for the rule or the objectives of the Lloyd family. While 
other NCAA policies also have deficiencies,140 the implications of the 
NCAA’s sickle cell trait testing policy and the duties it foists on team 
physicians and other athletic staff warrant attention from all who are 
concerned about the health and well-being of student-athletes. Testing 
for sickle cell trait could be beneficial to student-athletes if they are 
aware, informed, and able to take action to prevent a sickle cell trait 
related condition, and the test could also be valuable to student-
athletes in the future, when they may start a family, if they are aware 
of the result and its implications. But it is unclear that student-athletes 
are receiving such information or are given the tools to make use of it. 
At present, the clinical practices surrounding the screening of 
student-athletes for sickle cell trait appear unacceptable in several 
ways: student-athletes undergoing the test know far too little about it 
because the NCAA and its member institutions are not always 
meeting the obligations of informed consent; and student-athletes who 
learn that they are carriers of sickle cell trait may not understand the 
implications of that result or may be anxious without a chance to ask 
questions, because the NCAA and its member institutions do not 
routinely offer counseling. Yet the test is not benign. It could have 
substantial negative outcomes on and off the field, including a false 
sense of security that leads athletes to overlook symptoms of health 
problems in training or playing situations, and racist consequences for 
individual student-athletes when they seek employment or insurance. 
Further, while the test is intended to be beneficial, the testing policy is 
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not based on evidence and it is unclear whether student-athletes are 
benefitting from it. 
The NCAA’s mandated sickle cell trait test, one of the largest 
genetic screening programs in the country, is not merely one more 
rule in the NCAA handbook. Much more open and transparent 
discussion of the policy and the surrounding issues is needed in order 
for the testing to become legitimate, and for the testing policy to be 
implemented in a way that is fair to student-athletes. 
 
